About Us
Verve Therapeutics was created with a singular focus: to protect the world from cardiovascular disease
Our Mission
We are striving to build the preeminent company developing gene editing medicines to treat patients with cardiovascular disease, leveraging the expertise and capabilities of our team whose singular focus is on addressing the root causes of the world’s most common cause of death. Our goal is to disrupt today’s chronic care model for treating cardiovascular disease by providing a new therapeutic approach with single-course gene editing treatments.
Verve brings together multiple breakthroughs in 21st century biomedicine — human genetic analysis, gene editing, messenger RNA (mRNA) -based therapies and lipid nanoparticle (LNP) delivery — to realize a new future of longevity and vitality for tens of millions of people around the globe with or at risk for cardiovascular disease.
Verve Team
Verve has been purpose-built for the task ahead, with a team of world-leading experts in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development and commercialization.
Our Team
Felix Acheampong, Ph.D.
Senior Scientist, Mass Spectrometry
Michael Amaonye
Senior Research Associate, Editing and Discovery
Victoria Bartlett, Ph.D.
Vice President, Program and Alliance Management
Aaron Beach
Director, Analytical Development
Lisa Billings, MSc, CVT, rLAT
Associate Scientist, Preclinical Pharmacology
Souvik Biswas, Ph.D.
Principal Scientist, Chemistry and Formulation
Maurine Braun
Associate Director, Toxicology
Paul Casaz, Ph.D.
Director, Formulation and Characterization
Alexandra Chadwick, Ph.D.
Associate Director, Editing and Discovery
Holly Chan
Manager, CMC Project Management
Huei-Mei Chen, Ph.D.
Senior Scientist, Editing and Discovery
Christopher J. Cheng, Ph.D.
Executive Director, RNA Technology & Manufacturing
Victoria Clendaniel
Senior Research Associate, Preclinical Pharmacology
Angela Cook
Chief of Staff
Caitlin Crandall
Senior Process Development Engineer, RNA Technology & Manufacturing
Manashree Damle
Scientist, Computational Biology
Kristopher Davis
Operations Technician
Ishwin Dembla, M.S.
Senior Scientist, Analytics
Jamie DeNizio, Ph.D.
Senior Scientist, Editing and Discovery
Joseph DePeter
Senior Engineer, Process Development
Alex DiMario
Senior Manager, Supply Chain and Logistics
Andrew Dorsey
Research Associate, Formulation
Chaitali Dutta, Ph.D.
Associate Director, Preclinical Pharmacology
Robin Eisner
Facilities Operations Manager
Yasser (Yas) El-Gamal, J.D.
Vice President, Legal Affairs and Chief Intellectual Property Counsel
Richard Falzone
Vice President, Clinical Operations
Abril Fleitas Beitans
Associate Scientist, Editing and Discovery
Nicole Franaszek
Research Associate, Formulation
Nancy Fuselli, BSc, RAC
Senior Director, Quality Assurance
Jack Ganey
Associate Scientist, Editing and Discovery
Soumya Gangopadhyay, Ph.D.
Associate Principal Scientist, Bioanalysis
Sara Garcia, Ph.D.
Associate Principal Scientist, Computational Biology
Ryan Garrity
Senior Research Associate, Preclinical Pharmacology
Kevin Gichuru
Senior Manager, Accounting
Zachary Glass, Ph.D.
Scientist, Formulation
Kasey Goon
Associate Scientist, Bioanalysis
Matthew Greenfield
Associate Director, Laboratory Operations
Erin Hood
Senior Contracts Specialist
Hiep (Chris) Ho Huynh
Senior Accountant
Sowmya Iyer, Ph.D.
Associate Principal Scientist, Computational Biology
Paris James
Research Associate, RNA Technology
Hari Jayaram, Ph.D.
Vice President, Editing and Discovery
Christopher Johnson
Manager, External Quality Control
Lisa Kasiewicz, Ph.D.
Senior Scientist, Formulations
Jaime Kirk
Senior Manager, Technical Accounting
Danielle Klausman
Senior Manager, Regulatory Affairs
Sunita Kumar
Associate Director, Quality Assurance
Jeong-Ah Kwon
Scientist II, Analytics
Nick Laschkewitsch
Research Associate, Process Development
Jennifer Lavoie
Associate Director, CMC Project Management
Jay Lee
Associate Director, Financial Planning and Analysis
Richard Lee, Ph.D.
Senior Director, Preclinical Pharmacology and Translational Medicine
Jay Leipheimer
Scientist, RNA Technology
Jeffrey Li
Associate Scientist, Editing and Discovery
Jimmy Li
Staff Accountant
James Madsen, Ph.D.
Associate Director, Mass Spectrometry
Padma Malyala
Vice President, Formulation and Analytical Development
Jessica Mangano
Senior Engineer, Process Development
Yuri Matsumoto, Ph.D.
Associate Director, Bioanalysis
Anne Marie Mazzola
Study Manager, Preclinical Pharmacology and Toxicology
Harlisa Minaya
Senior Human Resources Generalist
Lauren Mineo
Executive Assistant, Research and Development
Ralitsa Mintcheva
Controller
Taiji Mizoguchi, Ph.D.
Associate Principal Scientist, Preclinical Pharmacology
Ash Nagpal
Senior Process Engineer
Robyn Naigles
Administrative and Operations Associate
Yusuf Nasrullah
Scientist, Editing and Discovery
April O'Neil
Associate Director, Human Resources
Alline Pacheco, Ph.D.
Senior Scientist, Editing and Discovery
Colin Platt, Ph.D.
Scientist, Bioanalysis
Brent V. Powell, Ph.D.
Scientist II, Analytics
Kallanthottathil G. Rajeev, Ph.D.
Vice President, CMC
Caroline Reiss, Ph.D.
Senior Scientist, RNA Technology
Huilan Ren
Scientist, Formulation
Jennifer Robinson
Vice President, Investor Relations and Corporate Communications
Ellen Rohde, Ph.D.
Vice President, Preclinical Pharmacology and Toxicology
Leocadia Ruiz
Director, External Quality Control
Chloe Salisbury
Quality Assurance Associate
Ivan Sandler
Associate Director, External Manufacturing
Athul Sanjeev
Research Associate, RNA Technology
Matthew Schmidt, Pharm.D.
Director, Regulatory Affairs
Derek Sethachutkul
Senior Director, External Manufacturing
Wynn Shatzer
Senior Research Associate, Analytics
Jax Shay
Senior Research Associate, Analytics
Andrew Sheely
Executive Director, Information Technology
Leya Siddiqui
Research Associate, Analytics
Dhinesh Kannan Srinivasan Kamalakkannan
Research Associate, Bioanalysis
Mary Stahley, Ph.D.
Associate Director, Process Development
Mila Stanojevic
Research Associate, Analytics
Nikolas Steege
Research Associate, Analytics
Casey Stevens, Ph.D.
Scientist, Process Development
Ryan Stoeckel
Associate Director, Procurement
Leslie Stolz, Ph.D.
Vice President, Regulatory Affairs
Lynnsey Street
Associate Scientist, Process Development
Eric Tillotson
Senior Engineer, Process Development
Scott Vafai, M.D.
Vice President, Translational Medicine
Kui Wang, Ph.D.
Associate Principal Scientist, RNA Technology
Chris Welch
Director, External Manufacturing
Francis Wong
Associate Scientist, Editing and Discovery
Leadership
Andrew Ashe, J.D.
President and Chief Operating Officer
Maggie Beaudoin
Vice President, Finance
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer and Chief Medical Officer
Allison Dorval
Chief Financial Officer
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Joan Nickerson
Senior Vice President, Human Resources and Facilities
Jason Politi
Senior Vice President, Technical Operations
Founders
Burt Adelman, M.D.
Co-Founder and Chairman of the Board
J. Keith Joung, M.D., Ph.D.
Co-Founder
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Issi Rozen, MBA
Co-Founder and Strategic Advisor
Barry Ticho, M.D., Ph.D.
Co-Founder
Scientific Advisory Board
Eugene Braunwald, M.D.
Scientific Advisory Board Member
Andrew Geall, Ph.D.
Scientific Advisory Board Member
Penny M. Heaton, M.D.
Scientific Advisory Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Daniel J. Rader, M.D.
Scientific Advisory Board Member
Collaborations and Licensing
Verve has assembled a portfolio of gene editing and delivery technologies through strategic collaborations and licensing agreements with industry leaders, including Beam Therapeutics, the Broad Institute, Harvard University and Acuitas Therapeutics, Inc.